Understanding Liver Cancer
Produced in partnership with the American Liver Foundation.
This patient education program is supported by educational grants from AstraZeneca Pharmaceuticals and Eisai Inc.
Recent advances have provided additional treatment options for patients with liver cancer. To benefit from those advances, patients need to be active participants in their care. Patients must feel empowered to engage in treatment decisions, advocate for equitable care, and communicate with their care team.
Find out more about the latest treatments by joining us for a 1-hour educational presentation featuring a panel of liver cancer specialists. You’ll gain a better understanding of how these therapies work and which patients are most likely to benefit from which therapies. You’ll also learn about strategies to help with treatment-associated side effects.
Hear from real-world patients about their experiences navigating associated stigma and barriers to care and effectively communicating with their care team. The program will also explore the role of clinical trials as a treatment option, the clinical-trial process, and how to find relevant ongoing trials.
Get answers to questions like:
- How will my care team determine my eligibility for newly available treatments?
- Should all patients join a surveillance program?
- What are combination treatments and why are they used?
- If my liver function is compromised, does this affect my treatment options?
- Are there any side effects with new or emerging treatments that patients should be aware of?
- I have experienced stigma based on my diagnosis; how do I address this?
- Are there resources or support groups available to me?
- Why should I consider clinical trials as a treatment option?
Register* now to watch anytime on demand.
*CancerCoachLive, a PlatformQ Health network learning channel, takes your privacy very seriously. Information we collect is primarily used to communicate with program participants, manage user accounts, recommend relevant programs, and perform data analyses to inform educational outcomes.
Ghassan Abou-Alfa, MD, MBA
Professor, Memorial Sloan Kettering Cancer Center
Mary Larsen, MSN, RN, OCN
Clinical Trials Nurse, Memorial Sloan Kettering Cancer Center
Mary Larsen, MSN, RN, OCN, is a Clinical Trials Nurse at Memorial Sloan Kettering Cancer Center (MSKCC) in the Solid Tumor Gastrointestinal service. She cares for patients on a wide range of national and international clinical trials. In 2014, Mary started her career at MSKCC as a Care Coordinator where she helped develop the “A Day in the Life” training module for new employees presented to all outpatient training classes. In 2018, Mary began her nursing career at MSKCC in the Hepatopancreaticobiliary Surgery and Gastrointestinal Medicine inpatient unit, taking care of patients throughout all stages of disease. In 2021, Mary transitioned to her current role in clinical trials. Also, Mary is an active member of Oncology Nursing Society, serving on the NYC Chapter Board since 2019.
Interview Participant - Liver Cancer Survivor, Liver Transplant Recipient, Recovering Alcoholic